Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study of MG2512 Injection in Participants With Advanced Solid Tumors (NCT07348653) | Shanghai Mabgen Biopharmaceutical Technology Co., Ltd. | 2026-03-18 |
Track Shanghai Mabgen Biopharmaceutical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.